Acute management of ventricular arrhythmias: Role of antiarrhythmic agents

Pharmacotherapy

Volumn 17, Issue 2 SUPPL., 1997, Pages

  Singh, Bramah N ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRETYLIUM; ENCAINIDE; FLECAINIDE; LIDOCAINE; MAGNESIUM SULFATE; PLACEBO; PROCAINAMIDE; SOTALOL;

CARDIOVERSION; CLINICAL TRIAL; CONFERENCE PAPER; CORONARY CARE UNIT; DEFIBRILLATION; DRUG EFFICACY; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE PACING; HEART VENTRICLE TACHYCARDIA; HEMODYNAMICS; HUMAN; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PRACTICE GUIDELINE; RESUSCITATION; TORSADE DES POINTES;

AMIODARONE; ANTI-ARRHYTHMIA AGENTS; CLINICAL TRIALS; ELECTRIC COUNTERSHOCK; HUMANS; TACHYCARDIA, VENTRICULAR; VENTRICULAR FIBRILLATION;

EID: 0030899818     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (32)

1. Singh BN. The coming of age of the class III antiarrhythmic principle: retrospective and future trends. Am J Cardiol 1996;78(4A suppl):17-27.
2. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989;321(6):406-12.
3. Teo KK, Yusuf S, Furberg CD. Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials. JAMA 1993;270(13):1589-95.
4. Hallstrom AP, Cobb LA, Yu BH, Weaver WD, Fahrenbruch CE. Antiarrhythmic drug experience in 941 patients resuscitated from an initial cardiac arrest between 1970 and 1985. Am J Cardiol 1991;68:1025-31.
5. Flaker GC, Blackshear JL, McBride R, Kronmal RA, Halperin JL, Hart RG. Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. J Am Coll Cardiol 1992;20:427-532.
6. Coplen SE, Antman EM, Berlin JA, Hewitt P, Chalmers TC. Efficacy and safety of quinidine therapy for the maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials. Circulation 1990;82:1106-16.
7. Morganroth J, Goin JE. Quinidine-related mortality in the short-to-medium-term treatment of ventricular arrhythmias: a meta-analysis. Circulation 1991;84:1977-83.
8. Mason JW. A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. N Engl J Med 1993;329:452-8.
9. The CASCADE Investigators. The CASCADE study -randomized anti-arrhythmic drug therapy in survivors of cardiac arrest in Seattle. Am J Cardiol 1993;72:280-7.
10. Wever EF, Hauer RNW, Van Capelle FJL, et al. Randomized study of implantable defibrillator as first-choice versus conventional strategy in post-infarct sudden death survivors. Circulation 1995;91:2195-203.
11. Singh B. Expanding indications for the use of class III agents in patients at high risk for sudden death. J Cardiovasc Electrophysiol 1995;6:887-900.
12. Singh BN. Antiarrhythmic actions of amiodarone: a profile of a paradoxical agent. Am J Cardiol 1996;78(suppl 4A):41-53.
13. Kowey PR, Levine JH, Herre JM, et al. Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent hemodynamically destabilizing ventricular tachycardia and fibrillation. Circulation 1995;92:3255-63.
14. Scheinman MM, Levine JH, Cannom DS, et al. Dose-ranging study of intravenous amiodarone in patients with life-threatening ventricular tachyarrhythmias. Circulation 1995;92:3264-72.
15. MacMahon S, Collins R, Peto R, Koster RW, Yusuf S. Effects of prophylactic lidocaine in suspected acute myocardial infarction. An overview of results from the randomized, controlled trials. JAMA 1988;260(13):1910-16.
16. Hine LK, Laird N, Hewitt P, Chalmers TC. Meta-analytic evidence against prophylactic lidocaine in acute myocardial infarction. Arch Intern Med 1989;149:2694-8.
17. Berntsen RF, Rasmussen K. Lidocaine to prevent ventricular fibrillation in the prehospital phase of suspected acute myocardial infarction: the north-Norwegian lidocaine intervention trial. Am Heart J 1992;124(6):1478-83.
18. Antman EM, Berlin JA. Declining incidence of ventricular fibrillation in myocardial infarction: implications for the prophylactic use of lidocaine. Circulation 1992;86:764-73.
19. Singh BN. Routine prophylactic lidocaine administration in acute myocardial infarction: an idea whose time is all but gone? Circulation 1992;86(3):1033-5.
20. Norris RM, Barnaby PF, Brown MA, et al. Prevention of ventricular fibrillation during acute myocardial infarction by intravenous propranolol. Lancet 1984;2:883-6.
21. ISIS-1 Collaborative Group. Randomized trial of intravenous atenolol among 16,027 cases of suspected myocardial infarction. Lancet 1986;2:57-60.
22. Holnloser S, Klingenheben T, Singh BN. Amiodarone-associated proarrhythmic effects: a review with special reference to torsades de pointes tachycardia. Ann Intern Med 1994;121:529-35.
23. Ho DS, Zecchin RP, Richards DA, Uther JB, Ross DL. Double-blind trial of lignocaine versus sotalol for acute termination of spontaneous ventricular tachycardia. Lancet 1994;344(8914): 18-23.
24. Bauman JL. Class III antiarrhythmic agents: the next wave. Pharmacotherapy 1997;17(2 pt 2):76S-83.
25. Helmy I, Herre JM, Gee G, et al. Use of intravenous amiodarone for emergency treatment of life-threatening ventricular arrhythmias. J Am Coll Cardiol 1988;12:1015-22.
26. Klein RC, Machell C, Rushforth N, et al. Efficacy of intravenous amiodarone as short-term treatment for refractory ventricular tachycardia. Am Heart J 1988;115:96-101.
27. Moos AN, Mohiuddin SM, Hee TT, et al. Efficacy and tolerance of high-dose intravenous amiodarone for recurrent, refractory ventricular tachycardia. Am J Cardiol 1990;65: 609-14.
28. Morady F, Scheinman MM, Shen E, et al. Intravenous amiodarone in the acute treatment of recurrent symptomatic ventricular tachycardia. Am J Cardiol 1983;51:156-9.
29. Nalos PC, Ismail Y, Pappas JM, et al. Intravenous amiodarone for short-term treatment of refractory ventricular tachycardia or fibrillation. Am Heart J 1991;122:1629-32.
30. Ochi RP, Goldenberg IF, Almquist A, et al. Intravenous amiodarone for the rapid treatment of life-threatening ventricular arrhythmias in critically ill patients with coronary artery disease. Am J Cardiol 1989;64:599-603.
31. Ryden L, Arciniego R, Arnonan K. A double-blind trial of metoprolol in acute myocardial infarction: effect on ventricular tachyarrhythmias. N Engl J Med 1983;308:614-18.
32. Ryan TJ, Anderson JL, Antman EM, et al. ACC/AHA guidelines for management of patients with acute myocardial infarction: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on the Management of Acute Myocardial Infarction). J Am Coll Cardiol 1996;28: 1328-1428.